Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesNuclear MedicinePET/MRI detects ‘unknown’ generators of musculoskeletal painPotential pain generators were identified by increased F-18 FDG radiotracer uptake on PET and/or structural abnormalities on MRI.3D PrintingDigital workflows, 3D models enhance preoperative planningWomens ImagingCryoablation treats early-stage breast cancer in older womenInterventionalStent procedure proves safe in pediatric liver transplant casesOrganized Radiology IssuesRadiology must persevere with sustainability efforts